Enrollment in the Affordable Care Act continues to erode as some customers struggle to make premium payments, with the declining numbers churning market uncertainty for insurers. In response, insurers ...

Improving hospital arrival times for AIS in patients with T2D is cost-effective, but primary prevention yields greater benefits.

Phase 4 COMPARE trial data show Nuvaxovid was associated with lower reactogenicity and fewer daily activity disruptions than mNEXSPIKE.

The EPA said last Monday it wants to roll back some regulations on "forever chemicals" in drinking water put into place in 2024.

The novel circular nanosecond pulsed field ablation catheter achieved acute electrical isolation in 100% of targeted pulmonary veins across all study participants. The single-shot nanosecond pulsed ...

A pooled analysis of patients receiving high-risk percutaneous coronary intervention revealed improved 90-day outcomes with Impella blood pump support compared with an intra-aortic balloon pump.

The FDA granted Priority Review to the novel Factor XIa inhibitor asundexian for secondary stroke prevention following an ischemic stroke.

Adults with poor mental health report worse self-rated overall health and more chronic illness, according to a study.

Researchers evaluated whether atrial fibrillation increases the risk for mechanical ventilation among patients with acute mesenteric ischemia.

A text-messaging intervention can improve patient activation and cardiovascular risk behaviors in adults with psoriasis.